152 related articles for article (PubMed ID: 23650051)
1. Role of Nrf2 in cancer photodynamic therapy: regulation of human ABC transporter ABCG2.
Ishikawa T; Kajimoto Y; Sun W; Nakagawa H; Inoue Y; Ikegami Y; Miyatake S; Kuroiwa T
J Pharm Sci; 2013 Sep; 102(9):3058-69. PubMed ID: 23650051
[TBL] [Abstract][Full Text] [Related]
2. Nrf2-dependent induction of human ABC transporter ABCG2 and heme oxygenase-1 in HepG2 cells by photoactivation of porphyrins: biochemical implications for cancer cell response to photodynamic therapy.
Hagiya Y; Adachi T; Ogura S; An R; Tamura A; Nakagawa H; Okura I; Mochizuki T; Ishikawa T
J Exp Ther Oncol; 2008; 7(2):153-67. PubMed ID: 18771089
[TBL] [Abstract][Full Text] [Related]
3. Critical role of ABCG2 in ALA-photodynamic diagnosis and therapy of human brain tumor.
Ishikawa T; Kajimoto Y; Inoue Y; Ikegami Y; Kuroiwa T
Adv Cancer Res; 2015; 125():197-216. PubMed ID: 25640271
[TBL] [Abstract][Full Text] [Related]
4. Enhancement of the Effect of Methyl Pyropheophorbide-a-Mediated Photodynamic Therapy was Achieved by Increasing ROS through Inhibition of Nrf2-HO-1 or Nrf2-ABCG2 Signaling.
Tian S; Yong M; Zhu J; Zhang L; Pan L; Chen Q; Li KT; Kong YH; Jiang Y; Yu TH; Yu LH; Bai DQ
Anticancer Agents Med Chem; 2017; 17(13):1824-1836. PubMed ID: 28356018
[TBL] [Abstract][Full Text] [Related]
5. Pivotal roles of peptide transporter PEPT1 and ATP-binding cassette (ABC) transporter ABCG2 in 5-aminolevulinic acid (ALA)-based photocytotoxicity of gastric cancer cells in vitro.
Hagiya Y; Endo Y; Yonemura Y; Takahashi K; Ishizuka M; Abe F; Tanaka T; Okura I; Nakajima M; Ishikawa T; Ogura S
Photodiagnosis Photodyn Ther; 2012 Sep; 9(3):204-14. PubMed ID: 22959800
[TBL] [Abstract][Full Text] [Related]
6. The sensitivity of cancer cells to pheophorbide a-based photodynamic therapy is enhanced by Nrf2 silencing.
Choi BH; Ryoo IG; Kang HC; Kwak MK
PLoS One; 2014; 9(9):e107158. PubMed ID: 25226504
[TBL] [Abstract][Full Text] [Related]
7. Expression of ABCG2 (BCRP) is regulated by Nrf2 in cancer cells that confers side population and chemoresistance phenotype.
Singh A; Wu H; Zhang P; Happel C; Ma J; Biswal S
Mol Cancer Ther; 2010 Aug; 9(8):2365-76. PubMed ID: 20682644
[TBL] [Abstract][Full Text] [Related]
8. Enhanced efficacy of photodynamic therapy by inhibiting ABCG2 in colon cancers.
Kim JH; Park JM; Roh YJ; Kim IW; Hasan T; Choi MG
BMC Cancer; 2015 Jul; 15():504. PubMed ID: 26149077
[TBL] [Abstract][Full Text] [Related]
9. Specific inhibition of the ABCG2 transporter could improve the efficacy of photodynamic therapy.
Bebes A; Nagy T; Bata-Csörgo Z; Kemény L; Dobozy A; Széll M
J Photochem Photobiol B; 2011 Nov; 105(2):162-6. PubMed ID: 21911299
[TBL] [Abstract][Full Text] [Related]
10. Nrf2-dependent and -independent induction of ABC transporters ABCC1, ABCC2, and ABCG2 in HepG2 cells under oxidative stress.
Adachi T; Nakagawa H; Chung I; Hagiya Y; Hoshijima K; Noguchi N; Kuo MT; Ishikawa T
J Exp Ther Oncol; 2007; 6(4):335-48. PubMed ID: 18038766
[TBL] [Abstract][Full Text] [Related]
11. Expression levels of PEPT1 and ABCG2 play key roles in 5-aminolevulinic acid (ALA)-induced tumor-specific protoporphyrin IX (PpIX) accumulation in bladder cancer.
Hagiya Y; Fukuhara H; Matsumoto K; Endo Y; Nakajima M; Tanaka T; Okura I; Kurabayashi A; Furihata M; Inoue K; Shuin T; Ogura S
Photodiagnosis Photodyn Ther; 2013 Sep; 10(3):288-95. PubMed ID: 23993855
[TBL] [Abstract][Full Text] [Related]
12. Human ABC transporter ABCG2 in cancer chemotherapy and pharmacogenomics.
Ishikawa T; Nakagawa H
J Exp Ther Oncol; 2009; 8(1):5-24. PubMed ID: 19827267
[TBL] [Abstract][Full Text] [Related]
13. Key Role of Human ABC Transporter ABCG2 in Photodynamic Therapy and Photodynamic Diagnosis.
Ishikawa T; Nakagawa H; Hagiya Y; Nonoguchi N; Miyatake S; Kuroiwa T
Adv Pharmacol Sci; 2010; 2010():587306. PubMed ID: 21188243
[TBL] [Abstract][Full Text] [Related]
14. The Cisplatin-Derived Increase of Mitochondrial Reactive Oxygen Species Enhances the Effectiveness of Photodynamic Therapy via Transporter Regulation.
Kurokawa H; Ito H; Matsui H
Cells; 2019 Aug; 8(8):. PubMed ID: 31426474
[TBL] [Abstract][Full Text] [Related]
15. Differential sensitivity in cell lines to photodynamic therapy in combination with ABCG2 inhibition.
Barron GA; Moseley H; Woods JA
J Photochem Photobiol B; 2013 Sep; 126():87-96. PubMed ID: 23911860
[TBL] [Abstract][Full Text] [Related]
16. Bioengineered NRF2-siRNA Is Effective to Interfere with NRF2 Pathways and Improve Chemosensitivity of Human Cancer Cells.
Li PC; Tu MJ; Ho PY; Jilek JL; Duan Z; Zhang QY; Yu AX; Yu AM
Drug Metab Dispos; 2018 Jan; 46(1):2-10. PubMed ID: 29061583
[TBL] [Abstract][Full Text] [Related]
17. Improvement of the efficacy of 5-aminolevulinic acid-mediated photodynamic treatment in human oral squamous cell carcinoma HSC-4.
Yamamoto M; Fujita H; Katase N; Inoue K; Nagatsuka H; Utsumi K; Sasaki J; Ohuchi H
Acta Med Okayama; 2013; 67(3):153-64. PubMed ID: 23804138
[TBL] [Abstract][Full Text] [Related]
18. Ubiquitin-mediated proteasomal degradation of non-synonymous SNP variants of human ABC transporter ABCG2.
Nakagawa H; Tamura A; Wakabayashi K; Hoshijima K; Komada M; Yoshida T; Kometani S; Matsubara T; Mikuriya K; Ishikawa T
Biochem J; 2008 May; 411(3):623-31. PubMed ID: 18237272
[TBL] [Abstract][Full Text] [Related]
19. Breast cancer resistant protein (BCRP) is a molecular determinant of the outcome of photodynamic therapy (PDT) for centrally located early lung cancer.
Usuda J; Tsunoda Y; Ichinose S; Ishizumi T; Ohtani K; Maehara S; Ono S; Tsutsui H; Ohira T; Okunaka T; Furukawa K; Sugimoto Y; Kato H; Ikeda N
Lung Cancer; 2010 Feb; 67(2):198-204. PubMed ID: 19477032
[TBL] [Abstract][Full Text] [Related]
20. The C421A (Q141K) polymorphism enhances the 3'-untranslated region (3'-UTR)-dependent regulation of ATP-binding cassette transporter ABCG2.
Ripperger A; Benndorf RA
Biochem Pharmacol; 2016 Mar; 104():139-47. PubMed ID: 26903388
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
